Back to search

Article

Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study

2024-02-01

Abstract excerpt

<h4>Background</h4> Artemisinin-based combination therapies (ACTs) are the recommended antimalarial drugs for the treatment of uncomplicated malaria. The recent emergence of artemisinin partial resistance (ART-R) in Rwanda, Uganda and Eritrea is of great concern. In Tanzania, a nationwide molecular malaria surveillance in 2021 showed a high prevalence of the Kelch13 (K13) 561H mutation in Plasmodium falciparum fr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3552ae4e-32e2-51a3-b588-930453378cdf
DOI
10.1101/2024.01.31.24301954
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers studyDOI 10.1101/2024.01.31.24301954
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.Semantic proximity
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.Semantic proximity
Emerging threat of Partial Artemisinin Resistance Markers in P. falciparum Parasite Populations in multiple geographical locations in high Transmission Regions of UgandaSemantic proximity
Expansion of Artemisinin Partial Resistance Mutations and Lack of Histidine Rich Protein-2 and -3 Deletions in<i>Plasmodium falciparum infections</i>from Rukara, RwandaSemantic proximity
Emergence and Spread of Plasmodium falciparum Kelch 13 Mutations in Selected Counties of Kenya: Implications for Responding to Artemisinin Partial Resistance.Semantic proximity
Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.Semantic proximity
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.Semantic proximity
Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023.Semantic proximity
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.Semantic proximity
Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda.Semantic proximity
Understanding the Global Spread of Artemisinin Resistance: Insights from over 100K <i>Plasmodium falciparum</i> SamplesSemantic proximity
Longitudinal surveillance of kelch13 identifies C469Y, P553L, R561H and A675V mutations associated with artemisinin resistance in Western KenyaSemantic proximity
Select a neighboring publication to make it the new centre.